Regulatory Policy

Attempts at regulating machines with human-like intelligence should be of pressing concern.

Maryland’s global budgeting scheme for hospitals may be a model for controlling rising health care prices.

New eligibility requirements for Medicaid threaten those who need coverage the most.

The permissive drug approval process enabled by the 21st Century Cures Act may cause public health problems.

Given its importance in scientific development, human subjects research requires close regulatory attention.

The time has come for repealing Medicaid’s Institutions for Mental Diseases Exclusion rule.

Although “Medicare for all” has picked up political traction, how it will materialize remains unclear.

Experts offer solutions to pressing issues in American health care.

The Better Regulation program, built over the past two decades, has allowed the EU to regulate more effectively.

Given the dangers of gun ownership, the firearms industry should be subject to warning label requirements.

Attempts to regulate “assault weapons” will be futile as long as the term lacks a clear definition.

An economic approach more fully captures the cost of gun violence than a public health approach.